Cloning and characterization of a functional promoter of the human SOCS-3 gene

Biochemical and Biophysical Research Communications

Volumn 301, Issue 2, 2003, Pages 386-391

  He, Biao ^a   You, Liang ^a   Uematsu, Kazutsugu ^a   Matsangou, Maria ^a   Xu, Zhidong ^a   He, Miao ^b   McCormick, Frank ^a   Jablons, David M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

293T cells; Human; Lung cancer; Promoter; SOCS 3; STAT3

Indexed keywords

GROWTH FACTOR; STAT PROTEIN; STAT3 PROTEIN;

ARTICLE; CANCER CELL; CONTROLLED STUDY; GENE ACTIVITY; GENE FUNCTION; GENETIC ANALYSIS; GENETIC PARAMETERS; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MOLECULAR CLONING; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; TATA BOX; WILD TYPE;

JANUS; MURINAE;

EID: 0037423763     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)03071-1     Document Type: Article

References (22)

1. O'Shea J., Jaks J. STATs, cytokine signal transduction, and immunoregulation: Are we there yet? Immunity. 7:1997;1-11.
2. Stark G.R., Kerrr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;227-264.
3. Darnell J.E. STATs and gene regulation. Science. 277:1997;1630-1635.
4. Krebs D.L., Hilton D.J. SOCS proteins: negative regulators of cytokine signaling. Stem Cells. 19(5):2001;378-387.
5. Hilton D.J., Richardson R.T., Alexander W.S., Viney E.M., Willson T.A., Sprigg N.S., Starr R., Nicholson S.E., Metcalf D., Nicola N.A. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA. 95:1998;114-119.
6. Naka T., Narazaki M., Hirata M.et al. Structure and function of a new STAT-induced STAT inhibitor. Nature. 387:1997;924-929.
7. Saito H., Morita Y., Fujimoto M.et al. IFN regulatory factor-1-mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 gene promoter by IFN-. γ J. Immunol. 164:2000;5833-5843.
8. Auernhammer C.J., Bousquet C., Melmed S. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc. Natl. Acad. Sci. USA. 96:1999;6964-6969.
9. Paul C., Seiliez I., Thissen J.P., Le Cam A. Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids: mRNA analysis and promoter characterization. Eur. J. Biochem. 267:2000;5849-5857.
10. Davey H.W., McLachlan M.J., Wilkins R.J.et al. STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver. Mol. Cell Endocrinol. 158:1999;111-116.
11. Emanuelli B., Peraldi P., Filloux C.et al. SOCS-3 is an insulin-induced negative regulator of insulin signaling. J. Biol. Chem. 275:2000;15985-15991.
12. Catlett-Falcone R., Dalton W.S., Jove R. STAT proteins as novel targets for cancer therapy. Curr. Opin. Oncol. 11:1999;1-8.
13. Huang M., Page C., Reynolds K., Lin J. Constitutive activation of STAT3 oncogene product in human ovarian carcinoma cells. Gynecol. Oncol. 79:2000;67-73.
14. Yoshikawa H., Matsubara K., Qian G.S., Jackson P., Groopman J.D., Manning J.E., Harris C.C., Herman J.G. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat. Genet. 28:2001;29-35.
15. Epling-Burnette P.K., Liu J.H., Catlett-Falcone R., Turkson J., Oshiro M., Kothapalli R., Li Y., Wang J.M., Yang-Yen H.F., Karras J., Jove R., Loughran T.P. Jr. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J. Clin. Invest. 107(3):2001;351-362.
16. Levy D.E., Darnell J.E. Jr. STATs: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3(9):2002;651-662.
17. O. Galm, H. Yoshikawa, M. Esteller, R. Osieka, J.G. Herman, SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma, Blood (2002) (in press).
18. Bowman T., Garcia R., Turkson J., Jove R. STATs in oncogenesis. Oncogene. 19:2000;2474-2488.
19. Song J.I., Grandis J.R. STAT signaling in head and neck cancer. Oncogene. 19:2000;2489-2495.
20. Lin T.S., Mahajan S., Frank D.A. The role of STAT5a and STAT5b in signaling by IL-2 family cytokines. Oncogene. 19:2000;2566-2576.
21. Coffer P.J., Koenderman L., de Groot R.P. The role of STATs in myeloid differentiation and leukemia. Oncogene. 19:2000;2511-2522.
22. Mora L.B., Buettner R., Seigne J., Diaz J., Ahmad N., Garcia R., Bowman T., Falcone R., Fairclough R., Cantor A., Muro-Cacho C., Livingston S., Karras J., Pow-Sang J., Jove R. Constitutive activation of STAT3 in human prostate tumors and cell lines: direct inhibition of STAT3 signaling induces apoptosis of prostate cancer cells. Cancer Res. 62(22):2002;6659-6666.